AR113131A2 - Inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc) - Google Patents

Inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)

Info

Publication number
AR113131A2
AR113131A2 ARP180102711A ARP180102711A AR113131A2 AR 113131 A2 AR113131 A2 AR 113131A2 AR P180102711 A ARP180102711 A AR P180102711A AR P180102711 A ARP180102711 A AR P180102711A AR 113131 A2 AR113131 A2 AR 113131A2
Authority
AR
Argentina
Prior art keywords
present description
amicrocitic
nsclc
immunotherapy against
against various
Prior art date
Application number
ARP180102711A
Other languages
English (en)
Spanish (es)
Inventor
Steffen Walter
Colette Song
Harpreet Singh
Jens Fritsche
Toni Weinschenk
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of AR113131A2 publication Critical patent/AR113131A2/es

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP180102711A 2013-08-05 2018-09-21 Inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc) AR113131A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1313987.8A GB201313987D0 (en) 2013-08-05 2013-08-05 Novel immunotherapy against several tumors, such as lung cancer including NSCLC

Publications (1)

Publication Number Publication Date
AR113131A2 true AR113131A2 (es) 2020-01-29

Family

ID=49224173

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180102711A AR113131A2 (es) 2013-08-05 2018-09-21 Inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)

Country Status (3)

Country Link
AR (1) AR113131A2 (fr)
GB (1) GB201313987D0 (fr)
MA (3) MA38794B1 (fr)

Also Published As

Publication number Publication date
MA42333A1 (fr) 2019-05-31
GB201313987D0 (en) 2013-09-18
MA46798B1 (fr) 2022-10-31
MA38794B1 (fr) 2019-04-30
MA46798A1 (fr) 2022-02-28
MA38794A1 (fr) 2017-12-29

Similar Documents

Publication Publication Date Title
PE20160717A1 (es) Nueva inmunoterapia contra diversos tumores como el cancer de pulmon, incluido el carcinoma de pulmon amicrocitico (nsclc)
CU20160060A7 (es) Péptidos, ácidos nucleicos y células, útiles en la inmunoterapia personalizada contra diversos tumores cerebrales y neuronales
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
CR20160531A (es) Inmunoterapia novedosa contra varios tumores de la sangre, como la leucemia mielógena aguda (lma)
MX355074B (es) Inmunoterapia novedosa contra varios tumores incluidos el cancer gastrico y gastrointestinal.
MX2019013163A (es) Inmunoterapia novedosa contra varios tumores de la sangre, con la leucemia mielogena aguda (lma).
MX2019013161A (es) Inmunoterapia personalizada contra diversos tumores cerebrales y neuronales.
AR118180A2 (es) Inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)
AR113131A2 (es) Inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)
AR100926A1 (es) Inmunoterapia contra varios tumores de la sangre, en particular contra la leucemia linfoide crónica (llc)
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc
MY193910A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194241A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC
EA202090822A2 (ru) Новый метод иммунотерапии нескольких видов опухолей, таких как рак легкого, включая нмрл

Legal Events

Date Code Title Description
FA Abandonment or withdrawal